(S)-2-(1-((Benzyloxy)carbonyl)pyrrolidin-3-yl)acetic acid

Catalog No. :
ACXDYO038
CAS No. :
219560-29-9
Molecular Formula :
C14H17NO4
Molecular Weight :
263.29

IUPAC Name:(S)-2-(1-((benzyloxy)carbonyl)pyrrolidin-3-yl)acetic acid

(S)-2-(1-((Benzyloxy)carbonyl)pyrrolidin-3-yl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$137.00Login to see priceIn stockInquiry
250mg97%$196.00Login to see priceIn stockInquiry
1g97%$490.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-(1-((Benzyloxy)carbonyl)pyrrolidin-3-yl)acetic acid
IUPAC Name(S)-2-(1-((benzyloxy)carbonyl)pyrrolidin-3-yl)acetic acid
Molecular FormulaC14H17NO4
Molecular Weight263.29
SMILESO=C(O)C[C@H]1CN(C(OCC2=CC=CC=C2)=O)CC1
InChI KeyIUYVTLSEDKQGQY-LBPRGKRZSA-N
Synonym(S)-N-benzyloxycarbonyl-homo-β-proline;(S)-2-(1-CBZ-PYRROLIDIN-3-YL)ACETIC ACID;3-Pyrrolidineacetic acid, 1-[(phenylmethoxy)carbonyl]-, (3S)-;(S)-2-(1-((Benzyloxy)carbonyl)pyrrolidin-3-yl)acetic acid;(S)-2-(1-((Benzyloxy)carbonyl)pyrrolidin-3-yl)acetic acid - [B91641]
CAS No.219560-29-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACXDYO038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXDYO038 route product structure diagram
    ACXDYO038219560-29-9 In Stock
Inquiry

2. ACXDYO038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEZLW561 route compound structure diagram
    ACEZLW561122442-02-8 In Stock
  4. Then
  5. ACXDYO038 route product structure diagram
    ACXDYO038219560-29-9 In Stock
Inquiry

Comments (0)